The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma
Abstract
Purpose: With whole-body magnetic resonance imaging (wb-MRI), almost the whole bone marrow compartment can be examined in patients with monoclonal plasma cell disease. Focal lesions (FLs) detected by spinal MRI have been of prognostic significance in symptomatic multiple myeloma (sMM). In this study, we investigated the prognostic significance of FLs in wb-MRI in patients with asymptomatic multiple myeloma (aMM). Patients and Methods: Wb-MRI was performed in 149 patients with aMM. The prognostic significance of the presence and absence, as well as the number, of FLs for progression into sMM was analyzed. Results: FLs were present in 28% of patients. The presence per se of FLs and a number of greater than one FL were the strongest adverse prognostic factors for progression into sMM (P < .001) in multivariate analysis. A diffuse infiltration pattern in MRI, a monoclonal protein of 40 g/L or greater, and a plasma cell infiltration in bone marrow of 20% or greater were other adverse prognostic factors for progression-free survival in univariate analysis. Conclusion: We recommend use of wb-MRI for risk stratification of patients with asymptomatic multiple myeloma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Myeloma Working Group (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04355.x · Cited by 2,321
Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
Kyle, R. A., Remstein, E. D., Therneau, T. M., Dispenzieri, A., Kurtin, P. J., Hodnefield, J. M., Larson, D. R., Plevak, M. F., Jelinek, D. F., Fonseca, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070389 · Cited by 921
On the exact distribution of maximally selected rank statistics
Hothorn, T., & Lausen, B. (2003) · Computational Statistics & Data Analysis · doi:10.1016/s0167-9473(02)00225-6 · Cited by 670
Maximally Selected Rank Statistics
Lausen, B., & Schumacher, M. (1992) · Biometrics · doi:10.2307/2532740 · Cited by 643
Dimopoulos, M., Terpos, E., Comenzo, R. L., Tosi, P., Beksac, M., Sezer, O., Siegel, D., Lokhorst, H., Kumar, S., Rajkumar, S. V., et al. (2009) · Leukemia · doi:10.1038/leu.2009.89 · Cited by 482
Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical Implications
Walker, R., Barlogie, B., Haessler, J., Tricot, G., Anaissie, E., Shaughnessy, J. D., Epstein, J., van Hemert, R., Erdem, E., Hoering, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5803 · Cited by 417
Ricci, C., Cova, M., Kang, Y. S., Yang, A., Rahmouni, A., Scott, W. W., & Zerhouni, E. A. (1990) · Radiology · doi:10.1148/radiology.177.1.2399343 · Cited by 417
Red and yellow marrow in the femur: age-related changes in appearance at MR imaging.
Moore, S. G., & Dawson, K. L. (1990) · Radiology · doi:10.1148/radiology.175.1.2315484 · Cited by 332
Whole-body (18)F-FDG PET identifies high-risk myeloma.
Durie, B. G. M., Waxman, A. D., D'Agnolo, A., & Williams, C. M. (2002) · PubMed · Cited by 272
Cesana, C., Klersy, C., Barbarano, L., Nosari, A., Crugnola, M., Pungolino, E. M., Gargantini, L., Granata, S., Valentini, M., & Morra, E. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1625 · Cited by 259
Efficient Screening of Nonnormal Regression Models
Lawless, J. F., & Singhal, K. (1978) · Biometrics · doi:10.2307/2530022 · Cited by 235
Dispenzieri, A., Rajkumar, S. V., Gertz, M. A., Lacy, M. Q., Kyle, R. A., Greipp, P. R., Witzig, T. E., Lust, J. A., Russell, S. J., Hayman, S. R., et al. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61029-x · Cited by 223
Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.
Lecouvet, F. E., Berg, B. C. V., Michaux, L., Malghem, J. J., Maldague, B., Jamart, J., Ferrant, A., & Michaux, J. (1998) · Radiology · doi:10.1148/radiology.209.3.9844655 · Cited by 138
Assessment of Optimal Selected Prognostic Factors
Lausen, B., Hothorn, T., Bretz, F., & Schumacher, M. C. (2004) · Biometrical Journal · doi:10.1002/bimj.200310030 · Cited by 136
Bäuerle, T., Hillengaß, J., Fechtner, K., Zechmann, C. M., Grenacher, L., Moehler, T. M., Heiß, C., Barbara, W.-G., Neben, K., Kauczor, H., et al. (2009) · Radiology · doi:10.1148/radiol.2522081756 · Cited by 127
Self-citationPrognostic features of asymptomatic multiple myeloma
Weber, D. M., Dimopoulos, M. A., Moulopoulos, L. A., Delasalle, K. B., Smith, T., & Alexanian, R. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.1122939.x · Cited by 122
Moulopoulos, L. A., Gika, D., Anagnostopoulos, Α., Delasalle, K. B., Weber, D. M., Alexanian, R., & Dimopoulos, M. A. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi362 · Cited by 121
Berenson, J. R. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.03.001 · Cited by 28
Cited by
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M.-V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70442-5 · Cited by 4,978
Self-citationLenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
Mateos, M.-V., Hernández, M.-T., Giraldo, P., de la Rubia, J., de Arriba, F., Corral, L. L., Rosiñol, L., Paiva, B., Palomera, L., Bargay, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300439 · Cited by 1,171
Kumar, S. K., Rajkumar, V., Kyle, R. A., van Duin, M., Sonneveld, P., Mateos, M.-V., Gay, F., & Anderson, K. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.46 · Cited by 1,177
Diagnosis and Management of Multiple Myeloma: A Review
Cowan, A. J., Green, D. J., Kwok, M., Lee, S., Coffey, D. G., Holmberg, L. A., Tuazon, S., Gopal, A. K., & Libby, E. N. (2022) · JAMA · doi:10.1001/jama.2022.0003 · Cited by 1,029
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Terpos, E., Kleber, M., Engelhardt, M., Zweegman, S., Gay, F., Kastritis, E., van de Donk, N. W. C. J., Bruno, B., Sezer, O., Broijl, A., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.117176 · Cited by 988
Metadata
- Authors
- Hillengass, J., Fechtner, K., Weber, M.-A., Bäuerle, T., Ayyaz, S., Heiss, C., Hielscher, T., Moehler, T. M., Egerer, G., Neben, K., Ho, A. D., Kauczor, H.-U., Delorme, S., & Goldschmidt, H.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-03-20
- Volume
- 28
- Issue
- 9
- Pages
- 1606-1610
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2158749770
- Cited by
- 381
- References
- 18
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.